Skip to content

Lung Cancer Blog

Everything about lung cancer is here.

Menu
  • Home
  • About Us
  • Lung Cancer
    • Lung Cancer News
    • Causes of Lung Cancer
    • Lung Cancer Symptoms
    • Types of Lung Cancer
    • Stages of Lung Cancer
    • Lung Cancer Treatment
    • Lung Cancer Drugs
    • Lung Cancer In Ayurveda
    • Chinese Herbs For Lung Cancer
  • Researches
  • Studies
  • Stories
  • Sitemap
  • Contact Us
Menu
lung | Lung Cancer

FDA Grants Approval to Amgen’s Treatment for deadly form of Lung Cancer

Posted on May 20, 2024
Post Views: 369

lung | Lung CancerEvery year, about 35k Americans are diagnosed with small cell lung cancer and the cancer usually has spread beyong the lung by the time it gets detected. The Food and Drug Administration has approved an innovative new treatment for patients with a form of lung cancer. The drug tarlatamab, or Imdelltra, made by company Amgen has received approval for the most deadly form of the disease. It is to be used only when all other options gave been exhausted to treat small cell lung cancer and have a life expectancy of just four to five months. The drug was able to tripled the life expectancy to 14 months.

This FDA approved Amgen’s bispecific T-cell engager tarlatamab, will now carry the brand name Imdelltra for the treatment of extensive-stage small lung cancer in patients having lung cancef progression on or after platinum chemotherapy. This Imedlltra has been approved under the regulator’s accelerated pathway and to maintain this approval, Amgen will need to verify Imedlltra’s clinical benefits in a Phase III confirmatory trial.

The drug has a side effect that can be serious. It may cause cytokine release syndrome. It is an over reaction of the immune system and can cause medical issues like rapid heartbeat, rash, low blood pressure etc. The standard treatment remains chemotherapy combined with immunotherapies but the small cell lung cancer resists the treatment.

Amgen is committed to helping ensure appropriate patients with access to Imdelltra. It is indicated for treatment of patients with extensive stage small cell lung cancer with disease progression on or after platinum based chemotherapy. Its continued approval may be contigent upon description of clinical benefit in confirmatory trials.

The information shared in this blog is for educational purposes only. For any healthcare needs, you should always consult with your medical practitioner.

Subscribe to our newsletter or follow us on Facebook or Twitter today and never miss out an update!

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X
  • Click to share on Pinterest (Opens in new window) Pinterest
  • Click to share on Threads (Opens in new window) Threads
  • Click to share on WhatsApp (Opens in new window) WhatsApp
  • Click to share on Reddit (Opens in new window) Reddit
  • Click to share on Tumblr (Opens in new window) Tumblr
  • Click to share on Pocket (Opens in new window) Pocket
  • Click to share on Telegram (Opens in new window) Telegram

Like this:

Like Loading...

Subscribe Us

Popular Articles

  • Lung Cancer Treatment in Ayurveda (7,322)
  • Lung Cancer: Symptoms and Treatment (5,651)
  • What is Non-Small-Cell Lung Cancer? (5,551)

Recent Comments

  • Lung Cancer on New Study To Help Advance Research In Lung Cancer
  • Laurie B Grimes on New Study To Help Advance Research In Lung Cancer
  • Lung Cancer on Asbestos and Lung Cancer – What’s The Link?

Recent Articles

  • Predicting Lung Cancer Risk with AI based Deep Learning Model May 26, 2025
  • FDA Grants Accelerated Approval to Telisotuzumab Vedotin-tllv for NSCLC May 19, 2025
  • Heart-Sparing Technique in Lung Cancer Radiotherapy May 12, 2025
  • Origins of Common Lung Cancer Linked to Smoking Discovered May 5, 2025
  • Lung Cancer Screening Is Beneficial For Non-Smokers As Well April 28, 2025

Lung Cancer Blog

Lung Cancer Blog provides all lung cancer related information for educational purposes.

Disclaimer

Some post may contain affiliate links, purchasing that product not going to cost extra but by your purchase Lung Cancer will get some little commission and that amount will help in surviving this website. So, please don’t hesitate to buy from these affiliate links.

Contact Us

If you have any query or suggestions about our blog, please feel free to email us at  lungcancersymptomsx@gmail.com.

Copyright © 2012 - 2025 Lung Cancer Blog. Wordpress by Vipasha.
  • Privacy Policy
  • About Us
  • Sitemap
  • Contact Us
%d